Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A den Broeder

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Rheumatology|July 7, 2025
Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world?Psm Groenen, N den Broeder, Mhm Wientjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 2017
[Polymyalgia rheumatica: new developments and challenges]D E Marsman, A A den Broeder, N Boers, et al.
Annals of the Rheumatic Diseases|April 17, 2001
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatmentA A den Broeder, F H van den Hoogen, L B van de Putte
RMD Open|June 3, 2016
Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologistsN Lesuis, A A den Broeder, M E J L Hulscher, et al.
Scandinavian Journal of Rheumatology|July 30, 2016
Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologistsN Lesuis, A A den Broeder, R F van Vollenhoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2009
Strong association between myotonic dystrophy type 2 and autoimmune diseasesA A Tieleman, A A den Broeder, A-E van de Logt, et al.
Rheumatology (Oxford, England)|June 6, 2002
Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alphaA A Den Broeder, M C W Creemers, A M van Gestel, et al.
The Netherlands Journal of Medicine|July 11, 2003
Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritisA A den Broeder, K J M Assmann, P L C M van Riel, et al.
Scandinavian Journal of Rheumatology|August 11, 2025
Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitorsL Nieboer, F Veenstra, L Verhoef, et al.
Clinical and Experimental Rheumatology|July 6, 2010
The use of different methods for rapid determination of the ESR induces DAS28 misclassification in clinical practiceA van der Maas, C H M van den Ende, J van Eerd, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Rheumatology|July 7, 2025
Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world?Psm Groenen, N den Broeder, Mhm Wientjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 2017
[Polymyalgia rheumatica: new developments and challenges]D E Marsman, A A den Broeder, N Boers, et al.
Annals of the Rheumatic Diseases|April 17, 2001
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatmentA A den Broeder, F H van den Hoogen, L B van de Putte
RMD Open|June 3, 2016
Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologistsN Lesuis, A A den Broeder, M E J L Hulscher, et al.
Scandinavian Journal of Rheumatology|July 30, 2016
Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologistsN Lesuis, A A den Broeder, R F van Vollenhoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2009
Strong association between myotonic dystrophy type 2 and autoimmune diseasesA A Tieleman, A A den Broeder, A-E van de Logt, et al.
Rheumatology (Oxford, England)|June 6, 2002
Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alphaA A Den Broeder, M C W Creemers, A M van Gestel, et al.
The Netherlands Journal of Medicine|July 11, 2003
Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritisA A den Broeder, K J M Assmann, P L C M van Riel, et al.
Scandinavian Journal of Rheumatology|August 11, 2025
Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitorsL Nieboer, F Veenstra, L Verhoef, et al.
Clinical and Experimental Rheumatology|July 6, 2010
The use of different methods for rapid determination of the ESR induces DAS28 misclassification in clinical practiceA van der Maas, C H M van den Ende, J van Eerd, et al.
Pageof 6